四川九洲(000801.SZ):終止發行股份購買資產並募集配套資金暨關聯交易事項
格隆匯5月28日丨四川九洲(000801.SZ)公佈,公司於2024年5月28日召開第十三屆董事會2024年度第五次會議、第十二屆監事會2024年度第五次會議,審議通過了《關於公司終止發行股份購買資產並募集配套資金暨關聯交易事項的議案》,同意公司終止發行股份購買資產並募集配套資金暨關聯交易事項。
自公司籌劃並首次公吿本次交易以來,公司嚴格按照相關法律法規要求,積極組織相關各方推進本次交易各項工作。交易各方對本次交易方案進行了多次論證和協商,因市場環境較本次交易籌劃之初發生了較大波動和變化,為切實維護公司及全體股東利益,公司和交易各方協商決定終止本次交易事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.